Skip to main content

Month: March 2020

Solar Alliance Provides COVID-19 Operations Update

VANCOUVER, British Columbia and KNOXVILLE, Tenn., March 18, 2020 (GLOBE NEWSWIRE) — Solar Alliance Energy Inc. (‘Solar Alliance’ or the ‘Company’) (TSX-V: SOLR, OTC: SAENF) is providing an operations update from CEO Myke Clark as the global community continues to deal with the COVID-19 outbreak.“First and foremost, we want to thank the health care professionals and first responders who are working so hard to keep us all safe,” said CEO Myke Clark. “Our thoughts and prayers are with anyone who has been impacted by this virus. At Solar Alliance, we are still working to provide our customers with solar energy systems, battery-based and generator backup systems and energy management solutions. While carrying out this work, the safety of our employees, customers and our community is paramount. We are taking appropriate measures to ensure...

Continue reading

Sanoma announces precautionary measures for AGM on 25 March 2020

Sanoma Corporation, Press Release, 18 March 2020 at 13:00 EETSanoma announces precautionary measures for AGM on 25 March 2020To decrease the risk of spread of coronavirus, Sanoma Corporation has decided to take a series of precautionary measures for the Annual General Meeting to be held on 25 March at 14 EET at Marina Congress Center in Helsinki.The measures are:All shareholders are strongly encouraged to follow the AGM through a live webcast and exercise their voting rights by proxy representation. We recommend this in particular to everyone who are especially vulnerable to the virus or have travelled outside Finland 14 days prior to the AGM. Anyone with flu symptoms or who has been exposed to the coronavirus is kindly requested not to attend the AGM in person. Due to the restrictions imposed by Finnish authorities, the number of participants...

Continue reading

Sanoman 25.3. pidettävään yhtiökokoukseen liittyvät ennaltaehkäisevät toimet

Sanoma Oyj, Lehdistötiedote, 18.3.2020 klo 13:00Sanoman 25.3. pidettävään yhtiökokoukseen liittyvät ennaltaehkäisevät toimetSanoma Oyj on päättänyt useista, 25. maaliskuuta 2020 klo 14 Marina Congress Centerissä Helsingissä järjestettävään varsinaiseen yhtiökokoukseen liittyvistä ennaltaehkäisevistä toimenpiteistä pienentääkseen koronaviruksen leviämisriskiä.Toimenpiteet ovat:Kaikkia osakkeenomistajia kannustetaan vahvasti seuraamaan yhtiökokousta verkossa ja käyttämään äänioikeuttaan valtakirjalla. Suosittelemme tätä erityisesti kaikille, jotka kuuluvat riskiryhmiin tai ovat matkustaneet Suomen ulkopuolella 14 vuorokauden aikana ennen yhtiökokousta. Kaikkia, joilla on flunssaoireita tai jotka ovat altistuneet koronavirukselle pyydetään ystävällisesti jättämään saapumatta yhtiökokoukseen. Viranomaismääräysten vuoksi paikalle tulevien...

Continue reading

Orchard Therapeutics Appoints Company Founder and Gene Therapy Pioneer Bobby Gaspar, M.D., Ph.D., as New Chief Executive Officer

— Mark Rothera steps down as President and CEO —— Frank Thomas takes on additional responsibilities as President and Chief Operating Officer —BOSTON and LONDON, March 18, 2020 (GLOBE NEWSWIRE) — Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced that company founder and gene therapy pioneer Bobby Gaspar, M.D., Ph.D., has been named chief executive officer, effective immediately. Dr. Gaspar, previously president of research, chief scientific officer, and a member of the Orchard board of directors, succeeds Mark Rothera, who has served as the company’s chief executive officer since 2017. As part of this transition process, Frank Thomas, Orchard’s chief operating officer and chief financial officer, will take on the role of president.“As a world-renowned scientist and physician,...

Continue reading

Las Vegas, Nevada – March 18, 2020 – Celexus, Inc. (OTCQB: CXUS)

LAS VEGAS, March 18, 2020 (GLOBE NEWSWIRE) — Celexus, Inc.  (OTCQB: CXUS), was notified that on February 12, 2020, the Securities and Exchange Commission (the “SEC”) issued an order temporarily suspending trading in the common stock of Celexus, Inc. (the “Company” or “CXUS”) on the OTC Bulletin Board and OTC Link for a period of 14 days ending on February 27, 2020. In its order, the SEC alleged that there were “questions that have been raised about the accuracy and adequacy of publicly disseminated information concerning, among other things, the company’s business combinations, related parties, relationship with its auditors, control persons, and business prospects.” Neither the Company nor Lisa Averbuch, its officer and director is aware of any untrue statements of material fact or any omission to state a material fact necessary...

Continue reading

Progyny, Inc. Provides Update on Impact of COVID-19

NEW YORK, March 18, 2020 (GLOBE NEWSWIRE) — Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today provided an update on the impact of the COVID-19 pandemic on its business.As part of its commitment to flatten the curve of COVID-19 and keep communities safe, all Progyny employees are working remotely. Progyny has the systems and processes in place to operate at full capacity from these remote locations. Additionally, Progyny has a strong balance sheet and financial resources to successfully weather any temporary interruption to its business.Progyny provided financial guidance on March 5, 2020, which excluded any potential impact from COVID-19. On March 17, 2020, the American Society for Reproductive Medicine (ASRM) issued guidance...

Continue reading

Generation Mining Appoints senior mining operator as Chief Operating Officer

TORONTO, March 18, 2020 (GLOBE NEWSWIRE) — Generation Mining Limited (CSE:GENM) (“Gen Mining”, “Generation”, or the “Company”) is pleased to announce the appointment of Drew Anwyll, M.Eng, P.Eng, as Chief Operating Officer. Mr. Anwyll’s mandate will be to initiate and oversee the execution of a Definitive Feasibility Study planned for 2020 and the restarting of permitting at the Marathon Palladium Project in Northern Ontario.Mr. Anwyll is a professional mining engineer with extensive experience in Northern Ontario and around the globe.  He has worked in roles ranging from contributing to the start-up and operation of one of the largest open pit gold mines in the world to president of a junior exploration company.Mr. Anwyll has worked extensively with Detour Gold, Barrick Gold, and Placer Dome along with various other junior and intermediate...

Continue reading

Sama to Begin Enhanced Exploration Program using Three Drill Rigs

MONTREAL, March 18, 2020 (GLOBE NEWSWIRE) — Sama Resources Inc. (“Sama” or the “Company”) (TSX-V: SME | OTC-PK: SAMMF) is pleased to announce enhanced exploration activities at its Nickel, Copper, Palladium projects in Ivory Coast, West Africa. The Company is currently exploring at three specific sites simultaneously over a strike length of 25 kilometers; Samapleu, Bounta and Yepleu.Figure 1: Sama 2020’s Typhoon and drilling program, showing numerous high intensity electromagnetic targets in the vicinity of the currently known mineralisation at Samapleu Main and Samapleu Extension.https://www.globenewswire.com/NewsRoom/AttachmentNg/3838a870-14f6-406f-b91c-430db3cf02a0The Company confirms excellent results using HPX TechCo Inc’s (“HPX”) proprietary Typhoon™ time-domain electromagnetic (TEM) geophysical transmitter (“Typhoon”) (using...

Continue reading

VSBLTY CEO PROVIDES CORPORATE UPDATE; COMPANY EXCEEDS ONE MILLION USD BOOKINGS IN Q1

Philadelphia, PA, March 18, 2020 (GLOBE NEWSWIRE) — VSBLTY Groupe Technologies Corp. (CSE: VSBY) (Frankfurt: 5VS) (OTC:VSBGF) (“VSBLTY”), a leading retail software technology company, has booked revenue exceeding one million USD in Q1 Co-founder & CEO Jay Hutton announced today as part of his 2020 CEO update.LINDA ROSANIO VSBLTY, INC 609-472-0877 LROSANIO@VSBLTY.NET

Continue reading

NCCN Updates Professional Guidelines Recommending Biomarker Testing for Unfavorable Intermediate and High-Risk Patients with Prostate Cancer

SALT LAKE CITY, March 18, 2020 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in molecular diagnostics and precision medicine, announced that the National Comprehensive Cancer Network (NCCN) updated its professional guidelines for prostate cancer to recommend biomarker-based testing for men with unfavorable intermediate and high-risk disease.  Myriad’s Prolaris test was one of only two prognostic tests for prostate cancer recommended by NCCN for the new expanded indications and is now broadly recommended for use in low, intermediate and high-risk disease. “NCCN’s endorsement of Prolaris testing in unfavorable intermediate and high-risk disease is a major step forward for men and will help in expanding access to testing,” said Todd D. Cohen, M.D., vice president of Medical Affairs for Urology at Myriad Genetics. ...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.